Back
Liquidia Vs. Arcturus Therapeutics Holdings Industry Stock Comparison
Buy
52
LQDA
Liquidia
Last Price:
10.12
Seasonality Move:
1.49%
Sell
44
ARCT
Arcturus Therapeutics Holdings
Last Price:
21.73
Seasonality Move:
-4.29%
Buy
52
Liquidia (LQDA)
is a Buy
Is Liquidia a Buy, Sell or Hold?
- The current Liquidia [LQDA] share price is $9.93. The Score for LQDA is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- LQDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings a Buy, Sell or Hold?
- The current Arcturus Therapeutics Holdings [ARCT] share price is $21.15. The Score for ARCT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- ARCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LQDA Stock Price Chart
ARCT Stock Price Chart
What is Arcturus Therapeutics Holdings's stock price today?
-
The Arcturus Therapeutics Holdings share price today is $21.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARCT is experiencing slight buying pressure.
LQDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 47.93 | Sell |
| Chaikin Money Flow: | 506422 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.25 - 10.01) | Buy |
| Bollinger Bands (100): | (10.32 - 13.22) | Sell |
ARCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 53.14 | Buy |
| Chaikin Money Flow: | 60238 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.63 - 21.51) | Buy |
| Bollinger Bands (100): | (19.36 - 31.14) | Sell |
LQDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.92 | Buy |
| 20-day SMA: | 9.59 | Buy |
| 50-day SMA: | 10.76 | Sell |
| 200-day SMA: | 12.44 | Sell |
| 8-day EMA: | 9.89 | Buy |
| 20-day EMA: | 9.94 | Sell |
| 50-day EMA: | 10.64 | Sell |
| 200-day EMA: | 11.3 | Sell |
ARCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.71 | Buy |
| 20-day SMA: | 20.31 | Buy |
| 50-day SMA: | 21.16 | Sell |
| 200-day SMA: | 29.08 | Sell |
| 8-day EMA: | 20.7 | Buy |
| 20-day EMA: | 20.55 | Buy |
| 50-day EMA: | 21.71 | Sell |
| 200-day EMA: | 26.18 | Sell |
Liquidia Earnings Growth & LQDA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $0.31 per share, a decrease this year of $0.69 per share, and an increase next year of $0.39 per share.
Arcturus Therapeutics Holdings Earnings Growth & ARCT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.60 per share, an increase next quarter of $1.49 per share, a decrease this year of $0.50 per share, and an increase next year of $1.47 per share.
Liquidia Technical Analysis
| Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arcturus Therapeutics Holdings Technical Analysis
| Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||